• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1070400-23
Device Problems Difficult to Remove (1528); Material Separation (1562)
Patient Problems Perforation (2001); Foreign Body In Patient (2687); Pericardial Effusion (3271)
Event Date 09/20/2019
Event Type  Death  
Manufacturer Narrative
Exemption number (b)(4).The device is expected to be returned for evaluation.It has not yet been received.A follow report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was performed to treat a proximal left anterior descending artery.Post stent implant of the 4.0x23mm xience xpedition stent, there was resistance felt with the anatomy due to a high degree of calcinosis and the delivery catheter separated at the guide wire exit notch.An attempt was made to press the distal portion to the artery wall using an unspecified stent then a stent graft but was unsuccessful and it remains in the patient.A perforation occurred resulting in pericardial effusion and the patient died.Per the physician, the cause of death was a coronary artery perforation and pericardial effusion.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no similar incidents from this lot.The reported patient effects of perforation, pericardial effusion and death are listed in the xience xpedition, everolimus eluting coronary stent system (eecss), instructions for use (ifu) as known patient effects of coronary stenting procedures.The investigation determined the reported difficulties appear to be related to the operational context of the procedure.A conclusive cause for the reported patient effect(s) and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.D10- device available for eval.Updated from yes to no.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9182545
MDR Text Key162050774
Report Number2024168-2019-12567
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 03/31/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/10/2022
Device Catalogue Number1070400-23
Device Lot Number9030541
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/20/2019
Initial Date FDA Received10/11/2019
Supplement Dates Manufacturer Received03/12/2020
Supplement Dates FDA Received03/31/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age59 YR
Patient Weight85
-
-